Navigation Links
Infants Malarial Risk Lowered by Preventive Measures

As a preventive measure, single dose of a common anti-malarial drug could help to reduce the risk of developing malaria in infants – study finds//.

According to a new study, intermittent preventive measures of giving anti-malarial drugs to 3, 4, and 9-month old-infants lowered their risk of contracting malaria in the future.

Malaria is one of the leading causes of death worldwide, causing an estimated 3,000 deaths each day and at least 300 million cases of severe illness each year, particularly among infants in sub-Saharan Africa. Prior attempts at prevention that relied on frequent administration of antimalarial drugs were unaffordable in the long run and might promote drug resistance. But intermittent preventive treatment, a more focused use of antimalarials at a few specific intervals, has proved promising in earlier studies.

Clara Menendez, MD, and her colleagues in Mozambique and Spain explored the intermittent administration of the antimalarial sulfadoxine-pyrimethamine (SP) to infants in their first year. Infants given SP at 3, 4, and 9 months of age were compared with those given a placebo at the same intervals.

Dr. Menendez and colleagues found that giving infants SP was safe and well tolerated, and reduced the incidence of hospital admissions by one fifth.

According to editorialists Feiko O. ter Kuile, MD, PhD, of the Liverpool School of Tropical Medicine and the U.S. Centers for Disease Control and Prevention, and Richard W. Steketee, MD, MPH, of the Malaria Control and Evaluation Partnership in Africa, ‘SP has a combination of features that may make it highly suitable for use as intermittent preventive treatment; it has relatively long half-lives, is very well tolerated in young infants, and it can be given as a single dose.’

Intermittent preventive treatment with sulfadoxine-pyrimethamine is seen by Drs. ter Kuile and Steketee to provide a satisfactory balance of safety and efficacy. There is ‘substantial protective efficacy of this approach,’ they said.

Source: Eurekalrt
'"/>




Related medicine news :

1. Banning Smoking in the Home Helps Infants
2. Benefits of Nitric Oxide in the Treatment of Premature Infants
3. New Technique to Study Infants Brain.
4. Limiting Infants Exposure To Smoke At Home
5. fMRI Offers Insight Into An Infants Brain
6. Drug Used To Improve Lung Function In Infants Could Slow Down Motor Coordination
7. Infants going to day-care may have lower risk of leukemia
8. Infants at lower risk from digestive disease if introduced to cereal early
9. New Blood Test To Detect Iron Level In Infants
10. Infants must be put to sleep in separate beds to prevent SIDS
11. Plump Infants Getting Obese Later In Life In More Cases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... ... My T Chai, a South African company that creates a number of ... a popular website specializing in sales of nutritional products. , Chai tea is ... It spread across Asia and Africa quickly, and today recipes vary from region to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As ... use of this type of healthcare model in the diagnosis and treatment of ...
(Date:4/24/2017)... , ... April 24, 2017 , ... As a former ... a thousand words. The good news for single women is that she put all ... is available on April 25th. Joan's insight, personal experiences and sparkling sense of humor ...
(Date:4/24/2017)... ... April 24, 2017 , ... A new global study of ... student well-being has seriously declined. "When disenfranchised youth from the heart of our ... State to turn the historic multi-ethnic and multi-religious powerhouses of the Middle East ...
(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: